Bicycle Therapeutics plc
BCYC
$4.01
-$0.18-4.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -190.41M | -219.03M | -218.96M | -250.66M | -242.36M |
| Total Depreciation and Amortization | 5.29M | 5.92M | 6.42M | 6.79M | 7.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.64M | 37.01M | 38.61M | 30.94M | 30.09M |
| Change in Net Operating Assets | -55.57M | -53.13M | -75.75M | -26.80M | -3.32M |
| Cash from Operations | -206.05M | -229.23M | -249.68M | -239.73M | -208.38M |
| Capital Expenditure | -2.23M | -2.46M | -2.35M | -2.14M | -1.91M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.23M | -2.46M | -2.35M | -2.14M | -1.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -196.00K | -191.00K | -168.00K | -162.00K | -31.99M |
| Issuance of Common Stock | 47.00K | 47.00K | 37.00K | 249.00K | 248.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -67.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -149.00K | -144.00K | -131.00K | 87.00K | -31.81M |
| Foreign Exchange rate Adjustments | -3.46M | -1.61M | 804.00K | -755.00K | 2.19M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -211.89M | -233.44M | -251.35M | -242.54M | -239.91M |